British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Sudha Sundar; Ranjit Manchanda; Charlie Gourley; Angela George; Andrew Wallace; Janos Balega; Sarah Williams; Yvonne Wallis; Richard Edmondson; Shibani Nicum; Jonathan Frost; Ayoma Attygalle; Christina Fotopoulou; Rebecca Bowen; Dani Bell; Ketankumar Gajjar; Bruce Ramsay; Nicholas J Wood; Sadaf Ghaem-Maghami; Tracie Miles; Raji Ganesan

doi:10.1136/ijgc-2020-002112

Article info

other Versions

You are currently viewing an earlier version of this article (January 08, 2022).
View the most recent version of this article

Review

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

Authors

Sudha Sundar Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UKInstitute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK PubMed articles Google scholar articles
Ranjit Manchanda Gynaecological Oncology, Barts Health NHS Trust, Barts Cancer Institute, London, UK PubMed articles Google scholar articles
Charlie Gourley University of Edinburgh Cancer Research UK Centre, Edinburgh, UK PubMed articles Google scholar articles
Angela George Royal Marsden Hospital NHS Trust, London, UK PubMed articles Google scholar articles
Andrew Wallace Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK PubMed articles Google scholar articles
Janos Balega Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UK PubMed articles Google scholar articles
Sarah Williams University Hospital Birmingham Foundation NHS Trust, Birmingham, UK PubMed articles Google scholar articles
Yvonne Wallis Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK PubMed articles Google scholar articles
Richard Edmondson University of Manchester, Manchester, UK PubMed articles Google scholar articles
Shibani Nicum Oxford University Hospitals NHS Trust, Oxford, UK PubMed articles Google scholar articles
Jonathan Frost Royal United Hospitals Bath NHS Foundation Trust, Bath, UK PubMed articles Google scholar articles
Ayoma Attygalle Pathology, Royal Marsden NHS Foundation Trust, London, UK PubMed articles Google scholar articles
Christina Fotopoulou Gynaecologic Oncology, Imperial Hospitals NHS trust, London, UK PubMed articles Google scholar articles
Rebecca Bowen Royal United Hospitals Bath NHS Foundation Trust, Bath, UK PubMed articles Google scholar articles
Dani Bell Macmillan Cancer Support, London, UK PubMed articles Google scholar articles
Ketankumar Gajjar Nottingham University Hospitals NHS Trust, Nottingham, UK PubMed articles Google scholar articles
Bruce Ramsay Peterborough City Hospital, Peterborough, Cambridgeshire, UK PubMed articles Google scholar articles
Nicholas J Wood Obstetrics and Gynaecology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK PubMed articles Google scholar articles
Sadaf Ghaem-Maghami Imperial College London, London, UK PubMed articles Google scholar articles
Tracie Miles Gynaecological Oncology, Royal United Hospitals, Bath, UK PubMed articles Google scholar articles
Raji Ganesan Birmingham Women’s and Children’s NHS Trust, Birmingham, UK PubMed articles Google scholar articles

Correspondence to Professor Sudha Sundar, Pan-Birmingham Gynaecological Cancer Centre, Birmingham B152TT, UK; sudha.sundar{at}nhs.net

View Full Text

Citation

Sundar S, Manchanda R, Gourley C, et al

British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom

International Journal of Gynecologic Cancer Published Online First: 19 January 2021. doi: 10.1136/ijgc-2020-002112

Publication history

Received October 5, 2020
Revision received December 6, 2020
Accepted December 9, 2020
First published January 19, 2021.

Article Versions

You are currently viewing a Previous version of this article (8 January 2022).
View the most recent version of this article

View clinical trial registration.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

other Versions

Authors

Citation

Publication history

Article Versions

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password